Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04383210
Title Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Elevation Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN | AUS


No variant requirements are available.